台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    60.0
  • 漲跌
    ▲0.2
  • 漲幅
    +0.33%
  • 成交量
    11
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-摩根大通 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

摩根大通 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/1000.00159.8059.60-191-1.10%
2025/01/0900.00160.2060.10-191-1.10%
2025/01/08160.5000.0060.401901.11%
2024/12/31160.60660.5061.10-590-5.51%
2024/12/3000.00461.0860.80-490-4.42%
2024/12/26861.4600.0061.108908.85%
2024/12/23261.00160.8061.401901.10%
2024/12/19160.9000.0061.001901.10%
2024/12/1700.00161.0060.70-191-1.10%
2024/12/1600.00362.0062.10-390-3.31%
2024/12/1100.00664.0064.00-690-6.65%
2024/11/2600.00265.5065.30-299-2.01%
2024/11/251164.7500.0065.40119911.07%
2024/11/22164.0000.0063.401961.03%
2024/11/2100.00263.1063.30-294-2.12%
2024/11/2000.001265.8264.40-1291-13.15%
2024/11/191668.98869.3069.308889.00%
2024/11/1800.00370.5370.70-390-3.31%
2024/11/15671.4000.0072.6061015.89%
2024/11/14872.43471.2369.7041023.88%
2024/11/131078.531077.4777.400970.00%
2024/11/1200.00186.1086.00-190-1.11%
2024/10/0800.00297.0097.00-2138-1.44%
2024/09/2700.00397.6097.70-3138-2.16%
2024/09/19596.5000.0096.5051393.59%
2024/09/12196.5000.0096.8011400.71%
2024/09/10197.50197.0096.5001390.00%
2024/09/09197.50298.4098.10-1137-0.73%
2024/09/0500.00199.7099.70-1140-0.71%
2024/09/0400.00298.4599.50-2141-1.41%
2024/08/191106.002105.00106.00-1130-0.77%
2024/08/166105.4200.00105.0061185.05%
2024/08/1400.002104.00104.50-2112-1.77%
2024/08/132103.001104.50101.5011090.92%
2024/08/124102.255102.00102.50-199-1.01%
2024/08/09699.65899.55100.50-293-2.14%
2024/08/0800.001103.50105.00-195-1.05%
2024/08/071108.0000.00108.001971.02%
2024/08/05399.0000.0098.803893.34%
2024/07/3000.003100.50100.50-389-3.35%
2024/07/112101.5000.00101.502942.11%
2024/07/011101.0000.00101.0011340.74%
2024/05/2900.001102.50102.50-1159-0.63%
2024/05/2000.001103.50103.50-1154-0.65%
2024/05/171105.0000.00105.5011520.66%
2024/05/161106.0000.00107.0011500.67%
2024/05/151102.0000.00104.0011480.67%
2024/05/14198.30498.80102.00-3144-2.07%
2024/05/0900.001118.50118.50-1119-0.83%
2024/05/0600.001119.00119.00-1118-0.84%
2024/05/0300.001118.50118.50-1117-0.85%
2024/05/0200.003117.50118.00-3116-2.57%
2024/04/3000.001117.50118.00-1116-0.86%
2024/04/2900.002117.50117.50-2116-1.72%
2024/04/2500.004117.00117.50-4115-3.45%
2024/04/2414118.0000.00118.001411512.10%
2024/04/172116.0000.00117.0021111.79%
2024/04/1100.001119.00119.50-1101-0.98%
2024/04/1020125.4321124.14127.00-195-1.04%
2024/04/0100.001122.50123.00-169-1.44%
2024/03/2900.001122.50122.00-168-1.47%
2024/03/256123.503123.50124.003624.79%
2024/03/212121.501122.00121.501581.71%
2024/03/202121.5000.00121.502563.54%
2024/03/1900.006123.25123.00-655-10.88%
2024/03/1800.001123.00124.00-151-1.95%
2024/03/151119.501120.50121.500470.00%
2024/03/144118.5000.00119.004439.24%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音